The Exopulse Mollii Suit from Ottobock fundamentally changes the treatment field of neurological disorders and related symptoms. It is the world’s first neuromodulation suit that makes use of a physiological reflex mechanism called reciprocal inhibition: By sending an electrical signal to an antagonistic muscle, the spastic muscle subsequently relaxes. The combined effect of relaxing tense muscles and enabling the activation of weak muscles allows its users to enjoy a more active and less painful daily life. It is a personal assistive medical device which is used for low-energy whole-body transcutaneous electrical stimulation, reducing the typical symptoms associated with neurological conditions such as cerebral palsy, multiple sclerosis, stroke or spinal cord injuries. This neuromodulation stimulation is non-invasive and non-pharmacological, and has limited side-effects compared to other known invasive or pharmacological treatments for spasticity and related chronic pain. It leads to positive effects as observed in clinical studies on range of motion, balance, hand-arm functions, gait and overall quality of life.